GMP Human PDGF-BB Protein
優(yōu)勢特色(Features)
1. Designed under ISO 9001:2015 and ISO 13485:2016
2. Manufactured and QC tested under a GMP compliance factory
3. Animal-Free materials
4. Beta-lactam materials free
5. Batch-to-batch consistency
6. Stringent quality control tests
7. No animal derived peptone and lactose used in production process
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
GMP Human PDGF-BB Protein (GMP-PDBH19) is expressed from E. coli cells. It contains AA Ser 82 - Thr 190 (Accession # P01127-1).
Predicted N-terminus: Met
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries no "tag".
The protein has a calculated MW of 12.4 kDa. The protein migrates as 13 kDa±3 kDa under reducing (R) condition (SDS-PAGE).
內(nèi)毒素(Endotoxin)
Less than 10 EU/mg by the LAL method.
宿主蛋白殘留(Host Cell Protein)
<0.5 ng/μg of protein tested by ELISA.
宿主核酸殘留(Host Cell DNA)
<0.02 ng/μg of protein tested by qPCR.
無菌(Sterility)
The sterility testing was performed by membrane filtration method described in CP<1101>, USP<71> and Eur. Ph. 2.6.1.
支原體(Mycoplasma)
Negative.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 20 mM Citric acid - Sodium Citrate, pH3.0 with protectants.
Contact us for customized product form or formulation.
運(yùn)輸(Shipping)
This product is supplied and shipped with blue ice, please inquire the shipping cost.
存儲(chǔ)(Storage)
Upon receipt, store it immediately at -20°C or lower for long term storage.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 5 years in lyophilized state;
-70°C for 12 months under sterile conditions after reconstitution.
ACRO GMP產(chǎn)品制造規(guī)范
ACROBiosystems GMP級(jí)產(chǎn)品是在質(zhì)量管理體系下生產(chǎn)的,并符合相關(guān)指南:
Ph. Eur General Chapter 5.2.12 Raw materials of biological origin for the production of cell-based and gene therapy medicinal products; USP <92> Growth Factors and Cytokines Used in Cell Therapy Manufacturing; USP <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products; ISO/TS 20399-1:2018, Biotechnology - Ancillary Materials Present During the Production of Cellular Therapeutic Products.
ACROBiosystems質(zhì)量管理體系內(nèi)容:
1. 根據(jù)ISO 9001:2015和ISO 13485:2016進(jìn)行設(shè)計(jì),在GMP工廠進(jìn)行制造和QC檢測
2. 無動(dòng)物成分
3. QA從批準(zhǔn)的供應(yīng)商處采購的材料
4. ISO 5潔凈室和自動(dòng)灌裝設(shè)備
5. 人員合格
6. 質(zhì)量保證審核和批準(zhǔn)質(zhì)量相關(guān)文件
7. 全批量生產(chǎn)和控制記錄
8. 設(shè)備維護(hù)和校準(zhǔn)
9. 分析程序的驗(yàn)證
10. 進(jìn)行的穩(wěn)定性研究
11. 全面的法規(guī)支持文件
ACROBiosystems對(duì)我們的GMP級(jí)產(chǎn)品提供嚴(yán)格的質(zhì)量控制測試(經(jīng)過充分驗(yàn)證的設(shè)備、工藝和測試方法),以確保它們?cè)诩兌取踩?、活性和批間穩(wěn)定性方面符合嚴(yán)格的標(biāo)準(zhǔn),每個(gè)批量QC批次主要包含以下具體信息:
1. SDS-PAGE
2. 蛋白質(zhì)含量
3. 內(nèi)毒素水平
4. 殘留宿主細(xì)胞DNA含量
5. 殘留宿主細(xì)胞蛋白質(zhì)含量
6. 生物活性分析
7. 微生物檢測
8. 支原體檢測
9. 體外病毒測定
10. 殘留水分
11. 批次間一致性
ACRO產(chǎn)品聲明
ACROBiosystems GMP級(jí)產(chǎn)品專為研究、生產(chǎn)或離體使用而設(shè)計(jì)。注意:不可直接供人體使用。
背景(Background)
PDGF在早期發(fā)育階段具有促有絲分裂作用,推動(dòng)未分化間充質(zhì)和一些祖細(xì)胞群的增殖。在成熟后期,PDGF信號(hào)傳導(dǎo)與組織重塑和細(xì)胞分化以及與模式和形態(tài)發(fā)生相關(guān)的誘導(dǎo)事件有關(guān)。除了驅(qū)動(dòng)間充質(zhì)細(xì)胞增殖外,PDGF還被證明在發(fā)育過程中和成年動(dòng)物中指導(dǎo)各種特化間充質(zhì)和遷移細(xì)胞類型的遷移、分化和功能。該家族中的其他生長因子包括在血管生成和內(nèi)皮細(xì)胞生長中具有活性的血管內(nèi)皮生長因子B和C(VEGF-B、VEGF-C),以及在血管生成中也具有活性的胎盤生長因子(PlGF)。PDGF在胚胎發(fā)育、細(xì)胞增殖、細(xì)胞遷移和血管生成中起著重要作用。PDGF是成纖維細(xì)胞(一種結(jié)締組織細(xì)胞)細(xì)胞分裂中的必需元素。眾所周知,PDGF可以維持少突膠質(zhì)祖細(xì)胞的增殖。血小板源性生長因子亞基B也稱為PDGFB、FLJ12858、PDGF2、SIS、SSV、c-SIS,是血小板源性增長因子家族的成員。PDGFB可以作為同二聚體(PDGF-BB)或與血小板衍生生長因子α多肽(PDGF-AB)的異二聚體存在,其中二聚體通過二硫鍵連接。該基因的突變與腦膜瘤有關(guān)。
關(guān)鍵字: GMP PDGF-BB;PDGF-BB;PDGF-BB蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。